Breast cancer is one of the most common types of cancer after lung cancer and the second leading cause of death in women. Globally, more than one million women are diagnosed with breast cancer annually. Breast cancer is mainly found in women compared to men. Though women of all ages are at risk of developing breast cancer, older woman have greater chances of developing it. The incidence rates of breast cancer vary noticeably; registering the highest rate in the US followed by Europe and the lowest rate in Africa and Asia.
Breast cancer usually affects women over the age of 40 and above. In the past few years, the cases of breast cancer have increased tremendously in western countries like the US and Europe. The breast cancer market is comprised of three segments: screening, diagnostic and treatment. The breast cancer market is driven by various factors like aging population in women, obesity, hormonal factors and family history amongst others.
The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancement in technology, a large number of companies are focusing to develop innovative breast cancer drugs. Further, the companies are forming alliances and agreements to develop effective treatment methods for breast cancer.
The stages of breast cancer are of critical importance and they alone determine the treatment method and the extent to which it can be cured. Mammography is believed to diagnose 85-90% of breast cancers in women over 50, and is capable of identifying a lesion one to four years before a lump can be felt. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by drugs and radiation therapy or both.
This report provides an overview of breast cancer, its types and stages, and incidence rates. The markets for screening, diagnosis and treatment of breast cancer, including mammography, biopsy, chemotherapy, radiotherapy and drugs, have been analyzed. It also analyzes the drivers, issues and trends in the breast care market. The major players in the market are profiled along with their financials and key business strategies.
Genetic testing, which is also known as DNA testing, is the latest innovation in the field of molecular diagnostics. The genetic testing market segment represents the highest growth opportunity compared to other segments within the molecular diagnostics market. The growth of the market is b ... more
The biosimilar market is presently a small segment of the pharmaceutical industry. However, in the years to come, the market for biosimilars has huge growth opportunity despite of the high entry barriers. The governments in the developed countries are desperately trying to control their nat ... more
Human being has evolved with an unending quest for exploration. With constant research in medical and other sciences, molecular diagnostic tools and techniques were developed. Besides providing the medical work and a wider spectrum and accuracy of test findings, these tests have also enable ... more